Michael King
Stock Analyst at EF Hutton
(0.80)
# 3,746
Out of 4,874 analysts
117
Total ratings
34.15%
Success rate
-16.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael King
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLM Apollomics | Maintains: Buy | $1,100 → $650 | $6.03 | +10,688.38% | 4 | Apr 1, 2024 | |
| SONN Sonnet BioTherapeutics Holdings | Assumes: Buy | $1,179 | $1.13 | +104,253.98% | 7 | Aug 23, 2023 | |
| LTRN Lantern Pharma | Reiterates: Buy | $11 | $3.11 | +253.70% | 10 | Aug 10, 2023 | |
| BMEA Biomea Fusion | Reiterates: Buy | $32 | $1.94 | +1,549.48% | 11 | Jun 26, 2023 | |
| JSPR Jasper Therapeutics | Reiterates: Buy | $69 | $5.57 | +1,130.91% | 10 | Jun 12, 2023 | |
| COEP Coeptis Therapeutics Holdings | Assumes: Buy | $200 | $8.40 | +2,280.95% | 7 | May 25, 2023 | |
| HOWL Werewolf Therapeutics | Assumes: Buy | $8.3 | $1.20 | +594.56% | 6 | May 25, 2023 | |
| REGN Regeneron Pharmaceuticals | Reiterates: Buy | $862 | $520.29 | +65.68% | 11 | May 1, 2023 | |
| EXEL Exelixis | Reiterates: Buy | $24 | $43.53 | -44.87% | 10 | Apr 28, 2023 | |
| AGEN Agenus | Reiterates: Buy | $166 | $4.93 | +3,267.14% | 8 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $8.56 | +390.65% | 5 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $304 | $321.94 | -5.57% | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $116 | $9.56 | +1,113.39% | 6 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.69 | +282.90% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $35.81 | -32.98% | 1 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $800 | $1.06 | +75,371.70% | 2 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $46 | $23.24 | +97.93% | 3 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $96 | $32.71 | +193.49% | 6 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $0.68 | +5,175.50% | 1 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.38 | +3,057.06% | 1 | Dec 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $7.07 | +338.47% | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $33 → $36 | $560.53 | -93.58% | 2 | Nov 13, 2017 |
Apollomics
Apr 1, 2024
Maintains: Buy
Price Target: $1,100 → $650
Current: $6.03
Upside: +10,688.38%
Sonnet BioTherapeutics Holdings
Aug 23, 2023
Assumes: Buy
Price Target: $1,179
Current: $1.13
Upside: +104,253.98%
Lantern Pharma
Aug 10, 2023
Reiterates: Buy
Price Target: $11
Current: $3.11
Upside: +253.70%
Biomea Fusion
Jun 26, 2023
Reiterates: Buy
Price Target: $32
Current: $1.94
Upside: +1,549.48%
Jasper Therapeutics
Jun 12, 2023
Reiterates: Buy
Price Target: $69
Current: $5.57
Upside: +1,130.91%
Coeptis Therapeutics Holdings
May 25, 2023
Assumes: Buy
Price Target: $200
Current: $8.40
Upside: +2,280.95%
Werewolf Therapeutics
May 25, 2023
Assumes: Buy
Price Target: $8.3
Current: $1.20
Upside: +594.56%
Regeneron Pharmaceuticals
May 1, 2023
Reiterates: Buy
Price Target: $862
Current: $520.29
Upside: +65.68%
Exelixis
Apr 28, 2023
Reiterates: Buy
Price Target: $24
Current: $43.53
Upside: -44.87%
Agenus
Mar 28, 2023
Reiterates: Buy
Price Target: $166
Current: $4.93
Upside: +3,267.14%
Feb 24, 2023
Reiterates: Buy
Price Target: $42
Current: $8.56
Upside: +390.65%
Feb 24, 2023
Reiterates: Buy
Price Target: $304
Current: $321.94
Upside: -5.57%
Feb 24, 2023
Maintains: Buy
Price Target: $123 → $116
Current: $9.56
Upside: +1,113.39%
Dec 16, 2022
Initiates: Buy
Price Target: $10
Current: $2.69
Upside: +282.90%
Mar 23, 2022
Initiates: Buy
Price Target: $24
Current: $35.81
Upside: -32.98%
Mar 11, 2022
Maintains: Buy
Price Target: $1,000 → $800
Current: $1.06
Upside: +75,371.70%
Mar 8, 2022
Maintains: Buy
Price Target: $43 → $46
Current: $23.24
Upside: +97.93%
Mar 3, 2022
Maintains: Buy
Price Target: $98 → $96
Current: $32.71
Upside: +193.49%
Jan 10, 2022
Initiates: Buy
Price Target: $36
Current: $0.68
Upside: +5,175.50%
Dec 23, 2021
Initiates: Buy
Price Target: $12
Current: $0.38
Upside: +3,057.06%
Nov 5, 2021
Maintains: Buy
Price Target: $25 → $31
Current: $7.07
Upside: +338.47%
Nov 13, 2017
Maintains: Market Outperform
Price Target: $33 → $36
Current: $560.53
Upside: -93.58%